应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AGIO Agios Pharmaceuticals, Inc.
休市中 04-26 16:00:00 EDT
31.49
-0.18
-0.57%
盘后
31.49
+0.00
0.00%
17:05 EDT
最高
32.01
最低
31.31
成交量
41.93万
今开
31.70
昨收
31.67
日振幅
2.21%
总市值
17.70亿
流通市值
14.99亿
总股本
5,619万
成交额
1,322万
换手率
0.88%
流通股本
4,760万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.00%报31.72美元
自选股智能写手 · 04-24
Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.00%报31.72美元
Agios Pharmaceuticals, Inc.盘中异动 股价大跌5.16%
自选股智能写手 · 04-13
Agios Pharmaceuticals, Inc.盘中异动 股价大跌5.16%
Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.42%
自选股智能写手 · 04-09
Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.42%
坎托菲茨杰拉德公司:重申Agios Pharmaceuticals(AGIO.US)增持评级。
智通财经 · 04-09
坎托菲茨杰拉德公司:重申Agios Pharmaceuticals(AGIO.US)增持评级。
Agios Pharmaceuticals Inc盘中异动 快速上涨5.05%
自选股智能写手 · 02-28
Agios Pharmaceuticals Inc盘中异动 快速上涨5.05%
Agios Pharmaceuticals Inc盘中异动 早盘股价大涨5.07%报31.29美元
自选股智能写手 · 02-23
Agios Pharmaceuticals Inc盘中异动 早盘股价大涨5.07%报31.29美元
美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra
Reuters · 02-23
美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra
Agios Pharmaceuticals Inc盘中异动 股价大涨5.30%报28.22美元
自选股智能写手 · 02-22
Agios Pharmaceuticals Inc盘中异动 股价大涨5.30%报28.22美元
Agios Pharmaceuticals Inc2023财年实现净利润-3.52亿美元,同比减少51.72%
自选股智能写手 · 02-19
Agios Pharmaceuticals Inc2023财年实现净利润-3.52亿美元,同比减少51.72%
美国研究综述-阿尔伯马尔、Dropbox、英伟达
Reuters · 02-16
美国研究综述-阿尔伯马尔、Dropbox、英伟达
美国研究综述-英伟达、Albemarle、Dropbox
Reuters · 02-16
美国研究综述-英伟达、Albemarle、Dropbox
美国研究综述-阿尔伯马尔、Dropbox、泰勒科技公司
Reuters · 02-16
美国研究综述-阿尔伯马尔、Dropbox、泰勒科技公司
Agios Pharmaceuticals Inc盘中异动 快速下挫5.03%报22.67美元
自选股智能写手 · 01-31
Agios Pharmaceuticals Inc盘中异动 快速下挫5.03%报22.67美元
Agios Pharmaceuticals Inc盘中异动 急速上涨5.16%报22.62美元
自选股智能写手 · 01-26
Agios Pharmaceuticals Inc盘中异动 急速上涨5.16%报22.62美元
Agios Pharmaceuticals Inc盘中异动 早盘急速上涨5.04%报23.98美元
自选股智能写手 · 01-04
Agios Pharmaceuticals Inc盘中异动 早盘急速上涨5.04%报23.98美元
更新版 1-Agios公司血液病药物达到后期研究目标
Reuters · 01-03
更新版 1-Agios公司血液病药物达到后期研究目标
Agios Pharmaceuticals Inc盘中异动 股价大涨5.07%报24.03美元
自选股智能写手 · 2023-12-23
Agios Pharmaceuticals Inc盘中异动 股价大涨5.07%报24.03美元
暂无数据
公司概况
公司名称:
Agios Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Agios Pharmaceuticals, Inc.于2007年8月7日在特拉华州注册成立。该公司是一家生物制药公司,致力于通过细胞代谢领域的领导地位改变患者的生活,目标是为罕见病创造差异化药物,重点是经典血液学。
发行价格:
--
{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals, Inc.","latestPrice":31.49,"timestamp":1714161600000,"preClose":31.67,"halted":0,"volume":419310,"hourTrading":{"tag":"盘后","latestPrice":31.49,"preClose":31.49,"latestTime":"17:05 EDT","volume":15801,"amount":497573.23,"timestamp":1714165531956},"delay":0,"floatShares":47600901,"shares":56194847,"eps":-6.326659,"marketStatus":"休市中","marketStatusCode":7,"change":-0.18,"latestTime":"04-26 16:00:00 EDT","open":31.7,"high":32.01,"low":31.31,"amount":13218307.4745,"amplitude":0.022103,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.326659,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":1374638400000,"adjPreClose":31.67,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":31.49,"preClose":31.49,"latestTime":"17:05 EDT","volume":15801,"amount":497573.23,"timestamp":1714165531956},"volumeRatio":0.4991975883785292},"requestUrl":"/m/hq/s/AGIO/tweets","defaultTab":"tweets","newsList":[{"id":"2429114352","title":"Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.00%报31.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429114352","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429114352?lang=zh_cn&edition=full","pubTime":"2024-04-24 01:08","pubTimestamp":1713892085,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日01时08分,Agios Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.00%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.68%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Palisade Bio, Inc.涨幅较大,Palisade Bio, Inc.、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃,换手率分别为2608.87%、180.30%、50.88%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Palisade Bio, Inc.,振幅分别为80.08%、56.09%、45.43%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240108057922b712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240108057922b712&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427759030","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427759030","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427759030?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:40","pubTimestamp":1712947253,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时40分,Agios Pharmaceuticals, Inc.股票出现波动,股价快速下挫5.16%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.54%。其相关个股中,Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃,换手率分别为3675.52%、1450.47%、102.76%,振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为93.97%、73.57%、58.59%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413024054861e55f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413024054861e55f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426811386","title":"Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426811386","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426811386?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:27","pubTimestamp":1712672823,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时27分,Agios Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.42%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。该信息摘要如下:坎托菲茨杰拉德公司:重申Agios Pharmaceuticals增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040922270487e7ee45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040922270487e7ee45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426589199","title":"坎托菲茨杰拉德公司:重申Agios Pharmaceuticals(AGIO.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426589199","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426589199?lang=zh_cn&edition=full","pubTime":"2024-04-09 20:36","pubTimestamp":1712666183,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司:重申Agios Pharmaceuticals(AGIO.US)增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409203625875a043c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409203625875a043c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414388788","title":"Agios Pharmaceuticals Inc盘中异动 快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414388788","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414388788?lang=zh_cn&edition=full","pubTime":"2024-02-28 01:23","pubTimestamp":1709054607,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日01时23分,Agios Pharmaceuticals Inc股票出现波动,股价急速上涨5.05%。Agios Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Janux Therapeutics Inc、Viking Therapeutics Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃,换手率分别为359.34%、198.03%、38.99%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Janux Therapeutics Inc、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为169.78%、104.30%、75.00%。Agios Pharmaceuticals Inc公司简介:Agios Pharmaceuticals Inc是一家生物制药公司,致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280123277a475931&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280123277a475931&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413767766","title":"Agios Pharmaceuticals Inc盘中异动 早盘股价大涨5.07%报31.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413767766","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413767766?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:57","pubTimestamp":1708700243,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时57分,Agios Pharmaceuticals Inc股票出现波动,股价大幅拉升5.07%。截至发稿,该股报31.29美元/股,成交量14.9166万股,换手率0.27%,振幅4.57%。Agios Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为1.04%。Agios Pharmaceuticals Inc公司简介:Agios Pharmaceuticals Inc是一家生物制药公司,致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322572387e72b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322572387e72b0b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413273894","title":"美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra","url":"https://stock-news.laohu8.com/highlight/detail?id=2413273894","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413273894?lang=zh_cn&edition=full","pubTime":"2024-02-23 15:28","pubTimestamp":1708673314,"startTime":"0","endTime":"0","summary":" 路透社2月23日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,其中包括 Biomarin Pharmaceutical、Intuit 和 Penumbra。要闻 * Biomarin Pharmaceutical Inc :Piper Sandler将目标价从115美元下调至107美元 * Intuit Inc :Susquehanna将目标价从700美元上调至775美元 * Penumbra Inc :摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413210769","title":"Agios Pharmaceuticals Inc盘中异动 股价大涨5.30%报28.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413210769","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413210769?lang=zh_cn&edition=full","pubTime":"2024-02-22 23:29","pubTimestamp":1708615766,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日23时29分,Agios Pharmaceuticals Inc股票出现波动,股价大幅拉升5.30%。截至发稿,该股报28.22美元/股,成交量10.4536万股,换手率0.19%,振幅5.52%。Agios Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.78%。Agios Pharmaceuticals Inc公司简介:Agios Pharmaceuticals Inc是一家生物制药公司,致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222232927791384ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222232927791384ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412997396","title":"Agios Pharmaceuticals Inc2023财年实现净利润-3.52亿美元,同比减少51.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412997396","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412997396?lang=zh_cn&edition=full","pubTime":"2024-02-19 00:19","pubTimestamp":1708273170,"startTime":"0","endTime":"0","summary":"12月31日,Agios Pharmaceuticals Inc公布财报,公告显示公司2023财年净利润为-3.52亿美元,同比减少51.72%;其中营业收入为26.82百万美元,同比增加88.34%,每股基本收益为-6.33美元。机构评级:截至2023年12月31日,当前有6家机构对Agios Pharmaceuticals Inc目标价做出预测,其中目标均价为40.83美元,其中最低目标价为29.00美元,最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219001938879e4558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219001938879e4558&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411686106","title":"美国研究综述-阿尔伯马尔、Dropbox、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2411686106","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411686106?lang=zh_cn&edition=full","pubTime":"2024-02-16 21:53","pubTimestamp":1708091615,"startTime":"0","endTime":"0","summary":" 路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,包括 Albemarle、Dropbox 和 Nvidia。要闻 * Albemarle Corp :摩根大通将目标价从130美元下调至115美元 * Bloom Energy Corp :KeyBanc将其评级从 \"增持 \"下调至 \"行业权重\"。* Dropbox Inc :摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp :奥本海默将目标价从650美元上调至850美元 * Tyler Technologies Inc :Piper Sandler将目标价从480美元上调至520美元 以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411251632","title":"美国研究综述-英伟达、Albemarle、Dropbox","url":"https://stock-news.laohu8.com/highlight/detail?id=2411251632","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411251632?lang=zh_cn&edition=full","pubTime":"2024-02-16 17:25","pubTimestamp":1708075529,"startTime":"0","endTime":"0","summary":" 路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,包括 Albemarle、Dropbox 和 Nvidia。要闻 * Albemarle Corp :摩根大通将目标价从130美元下调至115美元 * Deere & Co :大和资本市场将目标价从425美元下调至400美元 * Dropbox Inc :摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411635884","title":"美国研究综述-阿尔伯马尔、Dropbox、泰勒科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2411635884","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411635884?lang=zh_cn&edition=full","pubTime":"2024-02-16 15:19","pubTimestamp":1708067998,"startTime":"0","endTime":"0","summary":" 路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,包括 Albemarle、Dropbox 和 Tyler Technologies。要闻 * Albemarle Corp :摩根大通将目标价从130美元下调至115美元 * Deere & Co :大和资本市场将目标价从425美元下调至400美元 * Dropbox Inc :摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp :奥本海默将目标价从650美元上调至850美元 * Tyler Technologies Inc :Piper Sandler将目标价从480美元上调至520美元 以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2407908273","title":"Agios Pharmaceuticals Inc盘中异动 快速下挫5.03%报22.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407908273","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407908273?lang=zh_cn&edition=full","pubTime":"2024-01-31 04:14","pubTimestamp":1706645665,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日04时14分,Agios Pharmaceuticals Inc股票出现波动,股价大幅下挫5.03%。Agios Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Neximmune Inc、Pepgen Inc、Gri Bio Inc涨幅较大,Neximmune Inc、Panbela Therapeutics Inc、Gri Bio Inc较为活跃,换手率分别为1694.44%、301.80%、279.33%,振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、Gri Bio Inc,振幅分别为800.00%、218.65%、89.01%。Agios Pharmaceuticals Inc公司简介:Agios Pharmaceuticals Inc是一家生物制药公司,致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131041425790d8191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131041425790d8191&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406246172","title":"Agios Pharmaceuticals Inc盘中异动 急速上涨5.16%报22.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406246172","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406246172?lang=zh_cn&edition=full","pubTime":"2024-01-26 00:07","pubTimestamp":1706198820,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日00时07分,Agios Pharmaceuticals Inc股票出现异动,股价急速上涨5.16%。截至发稿,该股报22.62美元/股,成交量21.6022万股,换手率0.39%,振幅4.30%。Agios Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.06%。Agios Pharmaceuticals Inc公司简介:Agios Pharmaceuticals Inc是一家生物制药公司,致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401260007007a3e6778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401260007007a3e6778&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400387166","title":"Agios Pharmaceuticals Inc盘中异动 早盘急速上涨5.04%报23.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2400387166","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400387166?lang=zh_cn&edition=full","pubTime":"2024-01-04 00:07","pubTimestamp":1704298073,"startTime":"0","endTime":"0","summary":"北京时间2024年01月04日00时07分,Agios Pharmaceuticals Inc股票出现异动,股价快速拉升5.04%。截至发稿,该股报23.98美元/股,成交量72.8946万股,换手率1.30%,振幅9.48%。Agios Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.73%。Agios Pharmaceuticals Inc公司简介:Agios Pharmaceuticals Inc是一家生物制药公司,致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401040007537a3827d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401040007537a3827d7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400821956","title":"更新版 1-Agios公司血液病药物达到后期研究目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2400821956","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2400821956?lang=zh_cn&edition=full","pubTime":"2024-01-03 20:02","pubTimestamp":1704283324,"startTime":"0","endTime":"0","summary":"(在第1段中增加了有关整个研究和股票的详细信息) 路透1月3日 - Agios Pharmaceuticals 周三表示,在一项晚期研究中,该公司的药物帮助提高了一种遗传性血液病患者的血红蛋白水平,推动该公司股价在盘前交易中上涨了33%。这种名为米他匹伐的药物达到了研究的主要目标,因为与安慰剂相比,它在α-或β-地中海贫血患者中的血红蛋白反应有统计学意义的显著增加。在这项研究中,该药物还达到了次要目标,包括改善了患者的疲劳评分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2393573410","title":"Agios Pharmaceuticals Inc盘中异动 股价大涨5.07%报24.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393573410","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393573410?lang=zh_cn&edition=full","pubTime":"2023-12-23 04:48","pubTimestamp":1703278111,"startTime":"0","endTime":"0","summary":"北京时间2023年12月23日04时48分,Agios Pharmaceuticals Inc股票出现波动,股价大幅上涨5.07%。截至发稿,该股报24.03美元/股,成交量31.337万股,换手率0.56%,振幅4.46%。Agios Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为1.44%。Agios Pharmaceuticals Inc公司简介:Agios Pharmaceuticals Inc是一家生物制药公司,致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231223044832790320ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231223044832790320ad&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":0.0664},{"period":"1month","weight":0.0814},{"period":"3month","weight":0.3469},{"period":"6month","weight":0.5769},{"period":"1year","weight":0.4108},{"period":"ytd","weight":0.414}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Agios Pharmaceuticals, Inc.于2007年8月7日在特拉华州注册成立。该公司是一家生物制药公司,致力于通过细胞代谢领域的领导地位改变患者的生活,目标是为罕见病创造差异化药物,重点是经典血液学。","yearOnYearQuotes":[{"month":1,"riseRate":0.818182,"avgChangeRate":0.042769},{"month":2,"riseRate":0.636364,"avgChangeRate":0.059258},{"month":3,"riseRate":0.545455,"avgChangeRate":0.003251},{"month":4,"riseRate":0.545455,"avgChangeRate":0.003003},{"month":5,"riseRate":0.5,"avgChangeRate":0.042804},{"month":6,"riseRate":0.6,"avgChangeRate":0.032699},{"month":7,"riseRate":0.3,"avgChangeRate":-0.034242},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.049224},{"month":9,"riseRate":0.545455,"avgChangeRate":0.047807},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.015381},{"month":11,"riseRate":0.636364,"avgChangeRate":0.038309},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.013921}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals, Inc.","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Agios Pharmaceuticals, Inc.,AGIO,Agios Pharmaceuticals, Inc.股票,Agios Pharmaceuticals, Inc.股票老虎,Agios Pharmaceuticals, Inc.股票老虎国际,Agios Pharmaceuticals, Inc.行情,Agios Pharmaceuticals, Inc.股票行情,Agios Pharmaceuticals, Inc.股价,Agios Pharmaceuticals, Inc.股市,Agios Pharmaceuticals, Inc.股票价格,Agios Pharmaceuticals, Inc.股票交易,Agios Pharmaceuticals, Inc.股票购买,Agios Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}